Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jaishri O. Blakeley, MD
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Uab Comprehensive Cancer Center
Birmingham, Alabama, United States
- Jonsson Comprehensive Cancer Center at Ucla
Los Angeles, California, United States
- University of California San Francisco Medical Center
San Francisco, California, United States
- H. Lee Moffitt Cancer Center and Research Institute at University of South Florida
Tampa, Florida, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Josephine Ford Cancer Center at Henry Ford Hospital
Detroit, Michigan, United States
- Wake Forest University Comprehensive Cancer Center
Winston-Salem, North Carolina, United States
- Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, United States
- University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania, United States
- University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2010
- Primary completion
- 22 Jun 2012
- Completion
- 4 Mar 2014
- Last update posted
- 27 Dec 2017
- Registered enrollment
- 80
- Registry id
- NCT00895180
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.